Agilon Health (AGL) Common Equity (2020 - 2026)

Agilon Health (AGL) has reported Common Equity for 7 consecutive years, with $181.4 million the latest figure, recorded in Q1 2026.

• Common Equity for Q1 2026 came in at $181.4 million, down 63.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $181.4 million (down 63.73% YoY), and the FY2025 annual result was $126.7 million, down 73.09% from the prior year.
• Common Equity was $181.4 million for Q1 2026 at Agilon Health, up from $126.7 million in the prior quarter.
• Over five years, Common Equity peaked at $1.1 billion in Q1 2022 and troughed at $126.7 million in Q4 2025.
• Average Common Equity over 5 years is $692.3 million, with a median of $675.9 million recorded in 2024.
• Year-over-year, Common Equity soared 472.67% in 2022 and plunged 73.09% in 2025.
• Over 5 years, Common Equity stood at $1.0 billion in 2022, then slumped by 36.48% to $661.0 million in 2023, then dropped by 28.75% to $471.0 million in 2024, then slumped by 73.09% to $126.7 million in 2025, then soared by 43.16% to $181.4 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $181.4 million in Q1 2026, $126.7 million in Q4 2025, and $306.1 million in Q3 2025.